TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.

Roy F Chemaly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.